News
Semaglutide, widely used to treat diabetes and obesity, was associated with more than double the risk of developing ...
2d
Medindia on MSNDiabetes Drug Semaglutide Linked to Vision Loss RiskNew research shows GLP-1 drugs may be linked to a twofold increase in the risk of wet AMD among people with diabetes.
Weight loss from Ozempic may make the penis appear larger by reducing fat around the pubic area, but the drug itself is ...
Novo Nordisk’s drugs are being linked to an eye condition that can cause vision loss, while health tech companies made CNBC’s ...
2don MSN
People who take weight-loss drugs hoping to achieve the impressive results observed in large clinical trials may need to ...
WEIGHT loss jabs could prevent a medication taken by millions of women from working – and increase patients’ risk of cancer. The British Menopause Society said the jabs could cause ...
Hims & Hers Health is betting that the cash-pay market for weight-loss drugs will drive up customer demand although some ...
An international clinical trial, led in the UK by Swansea’s Joint Clinical Research Facility (JCRF), has found that ...
Options are emerging for the tens of millions of people who stop taking GLP-1 drugs because of side effects, cost or ...
Real-world results for blockbuster weight-loss meds like Ozempic, Wegovy and Zepbound aren't as impressive as those promised ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results